Suppr超能文献

小儿肾移植后的短暂性高磷酸酶血症

Transient Hyperphosphatasemia Following Pediatric Kidney Transplant.

作者信息

Cole Elisabeth B, Anslow Melissa, Fadakar Paul, Miyashita Yosuke, Ganoza Armando, Moritz Michael L

机构信息

Pediatric Nephrology, University of Pittsburgh Medical Center (UPMC) Children's Hospital of Pittsburgh, Pittsburgh, USA.

Hillman Center for Pediatric Liver Transplantation, University of Pittsburgh Medical Center (UPMC) Children's Hospital of Pittsburgh, Pittsburgh, USA.

出版信息

Cureus. 2021 Sep 3;13(9):e17697. doi: 10.7759/cureus.17697. eCollection 2021 Sep.

Abstract

Introduction Transient hyperphosphatasemia (TH) is a rare benign condition of elevated serum alkaline phosphatase (AP) levels seen in healthy children. TH has been reported to occur in pediatric solid organ transplants, including kidney transplant patients. Little is known about TH in pediatric kidney transplant patients. Objective To evaluate the incidence and natural history of TH in pediatric kidney transplant patients. Methods A retrospective chart review of patients < 18 years of age who underwent kidney transplantation at the University of Pittsburgh Medical Center (UPMC) Children's Hospital of Pittsburgh between 2008 and 2019 was performed to identify patients with TH, defined as an AP level greater than 1,000 IU/L. Exclusion criteria included repeat kidney transplants or kidney transplant as part of a multiorgan transplant. Results One hundred seventy-six patients underwent a solitary kidney transplant, of which 87 were less than 12 years of age. Eleven patients (6.5%) were found to have TH, all of whom were < 12 years of age (12.8%) (median age: 5 years; range: 1 - 11 years). The median AP level prior to transplant was 183 IU/L (range: 104 - 309 IU/L) and the median peak AP was > 2,300 IU/L (range: 1,227 - 4,912 IU/L). The median time from a kidney transplant to the diagnosis of TH was 0.6 years (range: 0.3 to 7.7 years). The median length of time that TH persisted was 0.5 years (range: 0.2 to 0.9 years). The median estimated glomerular filtration rate (GFR) at the time of diagnosis of TH was 84 mL/min/1.73m per the bedside Schwartz equation (range: 45 to 152 mL/min/1.73m). One patient had variable AP levels over nine months prior to resolution; the other 10 patients had a solitary peak of AP prior to resolution. No patient required treatment of elevated AP levels and the TH resolved spontaneously without intervention. No patients had significant abnormalities of markers of metabolic bone disease or were on active vitamin D, calcium, or phosphorus supplements. Two patients reported bone pain, and one patient was found to have avascular necrosis of the hip. Conclusions TH is a relatively common finding following a pediatric kidney transplant in pre-pubertal children less than 12 years of age. It primarily occurs in the first year following a kidney transplant and usually resolves without recurrence within one year of onset.

摘要

引言

短暂性高磷酸酶血症(TH)是一种在健康儿童中出现的血清碱性磷酸酶(AP)水平升高的罕见良性病症。据报道,TH发生在小儿实体器官移植中,包括肾移植患者。关于小儿肾移植患者的TH知之甚少。

目的

评估小儿肾移植患者中TH的发病率和自然病程。

方法

对2008年至2019年期间在匹兹堡大学医学中心(UPMC)匹兹堡儿童医院接受肾移植的18岁以下患者进行回顾性病历审查,以确定患有TH的患者,定义为AP水平大于1000 IU/L。排除标准包括重复肾移植或作为多器官移植一部分的肾移植。

结果

176例患者接受了单肾移植,其中87例年龄小于12岁。11例患者(6.5%)被发现患有TH,所有患者均小于12岁(12.8%)(中位年龄:5岁;范围:1 - 11岁)。移植前AP的中位水平为183 IU/L(范围:104 - 309 IU/L),AP的中位峰值大于2300 IU/L(范围:1227 - 4912 IU/L)。从肾移植到诊断为TH的中位时间为0.6年(范围:0.3至7.7年)。TH持续的中位时间为0.5年(范围:0.2至0.9年)。根据床边施瓦茨方程,诊断TH时估计肾小球滤过率(GFR)的中位值为84 mL/min/1.73m²(范围:45至152 mL/min/1.73m²)。1例患者在恢复前九个月AP水平有变化;其他10例患者在恢复前有一个AP峰值。没有患者需要对升高的AP水平进行治疗,TH在没有干预的情况下自发缓解。没有患者有代谢性骨病标志物的明显异常,也没有服用活性维生素D、钙或磷补充剂。2例患者报告有骨痛,1例患者被发现有髋关节缺血性坏死。

结论

TH是12岁以下青春期前小儿肾移植后相对常见的发现。它主要发生在肾移植后的第一年,通常在发病后一年内自行缓解且无复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0fe/8487752/7139fc78d3f6/cureus-0013-00000017697-i01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验